Congenital muscular dystrophy (disorder)
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Congenital muscular dystrophy with laminin-α2 deficiency, also known as MDC1A, displays an extensive phenotypic and genetic heterogeneity.
|
30900984 |
2020 |
Congenital muscular dystrophy (disorder)
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
To identify the rate of change of clinical outcome measures in children with 2 types of congenital muscular dystrophy (CMD), COL6-related dystrophies (COL6-RDs) and LAMA2-related dystrophies (LAMA2-RDs).
|
31653707 |
2019 |
Congenital muscular dystrophy (disorder)
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
LAMA2 mutations cause the most frequent congenital muscular dystrophy subtype MDC1A and a variety of milder phenotypes, characterized by total or partial laminin-α2 deficiency.
|
31040037 |
2019 |
Congenital muscular dystrophy (disorder)
|
0.500 |
Biomarker
|
disease |
BEFREE |
Early skeletal muscle pathology and disease progress in the dy<sup>3K</sup>/dy<sup>3K</sup> mouse model of congenital muscular dystrophy with laminin α2 chain-deficiency.
|
31586140 |
2019 |
Congenital muscular dystrophy (disorder)
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Our pulse generator significantly increases fiber detachment in the laminin-α2 deficient, congenital muscular dystrophy type 1a (MDC1a) model lama2<sup>-/-</sup> fish when compared with controls.
|
29381425 |
2018 |
Congenital muscular dystrophy (disorder)
|
0.500 |
Biomarker
|
disease |
BEFREE |
Congenital muscular dystrophy with laminin α2 chain-deficiency (LAMA2-CMD) is a severe muscle disorder with complex underlying pathogenesis.
|
30389963 |
2018 |
Congenital muscular dystrophy (disorder)
|
0.500 |
Biomarker
|
disease |
BEFREE |
This approach has also been explored in several other genetic disorders, including laminin α2 chain-deficient congenital muscular dystrophy, dysferlin-deficient muscular dystrophy (e.g., Miyoshi myopathy and limb-girdle muscular dystrophy type 2B), sarcoglycanopathy (limb-girdle muscular dystrophy type 2C), and Fukuyama congenital muscular dystrophy.
|
29067661 |
2018 |
Congenital muscular dystrophy (disorder)
|
0.500 |
Biomarker
|
disease |
BEFREE |
Congenital muscular dystrophy type 1A (MDC1A) is one of the main subtypes of early-onset muscle disease, caused by disease-associated variants in the laminin-α2 (LAMA2) gene.
|
30055037 |
2018 |
Congenital muscular dystrophy (disorder)
|
0.500 |
Biomarker
|
disease |
BEFREE |
Electrical impedance myography in individuals with collagen 6 and laminin α-2 congenital muscular dystrophy: a cross-sectional and 2-year analysis.
|
28224647 |
2018 |
Congenital muscular dystrophy (disorder)
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Identification of Two Novel LAMA2 Mutations in a Chinese Patient with Congenital Muscular Dystrophy.
|
29487616 |
2018 |
Congenital muscular dystrophy (disorder)
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Laminin-deficient congenital muscular dystrophy (LAMA2-CMD) is a severe form of congenital muscular dystrophy caused by mutations in the gene encoding laminin α2 chain.
|
28771630 |
2017 |
Congenital muscular dystrophy (disorder)
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Congenital muscular dystrophy type MDC1A is caused by mutations in laminin α2 that either reduce its expression or impair its ability to polymerize within the muscle fiber BM.
|
28218619 |
2017 |
Congenital muscular dystrophy (disorder)
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Mutations in laminin α2-subunit (Lmα2, encoded by LAMA2) are linked to approximately 30% of congenital muscular dystrophy cases.
|
28218617 |
2017 |
Congenital muscular dystrophy (disorder)
|
0.500 |
Biomarker
|
disease |
BEFREE |
Congenital muscular dystrophy type 1A (MDC1A) is a devastating form of muscular dystrophy caused by laminin α2 chain-deficiency.
|
28281577 |
2017 |
Congenital muscular dystrophy (disorder)
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Recessive mutations in LAMA2 commonly cause congenital muscular dystrophy (MDC1A) and, rarely, limb girdle muscular dystrophy (LGMD).
|
27932089 |
2017 |
Congenital muscular dystrophy (disorder)
|
0.500 |
Biomarker
|
disease |
BEFREE |
Congenital muscular dystrophy type 1A (MDC1A) is a severe muscle disorder caused by mutations in the LAMA2 gene.
|
28367954 |
2017 |
Congenital muscular dystrophy (disorder)
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
We assessed the ability of EIM ability to discriminate 2 forms of congenital muscular dystrophy (CMD), laminin α2 (LAMA2)-deficient CMD and collagen VI-deficient (COL6) CMD, from a group of healthy children.
|
26179210 |
2016 |
Congenital muscular dystrophy (disorder)
|
0.500 |
Biomarker
|
disease |
BEFREE |
Inflammation and fibrosis are well-defined mechanisms involved in the pathogenesis of the incurable Laminin α2-deficient congenital muscular dystrophy (MDC1A), while apoptosis mechanism is barely discussed.
|
25766329 |
2015 |
Congenital muscular dystrophy (disorder)
|
0.500 |
Biomarker
|
disease |
BEFREE |
LAMA2-related congenital muscular dystrophy complicated by West syndrome.
|
25500573 |
2015 |
Congenital muscular dystrophy (disorder)
|
0.500 |
Biomarker
|
disease |
BEFREE |
Potential therapies are currently under development for two congenital muscular dystrophy (CMD) subtypes: collagen VI-related muscular dystrophy (COL6-RD) and laminin alpha 2-related dystrophy (LAMA2-RD).
|
25307854 |
2015 |
Congenital muscular dystrophy (disorder)
|
0.500 |
Biomarker
|
disease |
BEFREE |
Genotype/phenotype analysis in Chinese laminin-α2 deficient congenital muscular dystrophy patients.
|
24611677 |
2015 |
Congenital muscular dystrophy (disorder)
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Muscular dystrophy caused by LAMA2-gene mutations is an autosomal recessive disease typically presenting as a severe, early-onset congenital muscular dystrophy (CMD).
|
25663498 |
2015 |
Congenital muscular dystrophy (disorder)
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Targeted next generation sequencing reveals a novel intragenic deletion of the LAMA2 gene in a patient with congenital muscular dystrophy.
|
25544356 |
2015 |
Congenital muscular dystrophy (disorder)
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Primary deficiency of laminin alpha-2 due to mutations in the LAMA2 gene accounts for 30% of all patients with congenital muscular dystrophy.
|
24225367 |
2014 |
Congenital muscular dystrophy (disorder)
|
0.500 |
Biomarker
|
disease |
BEFREE |
Highly efficient in vivo delivery of PMO into regenerating myotubes and rescue in laminin-α2 chain-null congenital muscular dystrophy mice.
|
23882132 |
2013 |